Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05860517
Other study ID # RIPHAH/RCRS/REC/Letter-01269
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 5, 2023
Est. completion date July 15, 2023

Study information

Verified date October 2023
Source Riphah International University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a tool translation an validation study. CPCHILD will be translated in Urdu language and it's translated version will be validated. Translated version's reliability and validity will also be assessed. The WHO guidelines for tool translation study will be followed.


Description:

Phase 1: Translation Translation of English version of CPCHILD into Urdu version will be done according to the WHO guidelines. Step I: Forward translation (one way) into target language: A linguistic expert with bilingual (English and Urdu) expertise will translate the original English version into Urdu. Step II: Synthesis: An independent bilingual translator will then compare the translated version (Urdu) with the original version (English) of the instrument. Step III: Blind Backward translation: A blinded backward translation of initially translated version will be done. Bilingual expert with preferably having Urdu as his/her mother language will be blinded to original version, will translate Urdu version into English. Step IV: Pretesting: 10 subjects including translators, physical therapists and researchers will fill out the questionnaire before submission of final version. Step V: Expert (multidisciplinary) committee review: An expert committee including translators, researchers, and health care practitioner would develop a pre-final version after reviewing all the translations. Phase 2: Psychometric testing Full psychometric testing of the CPCHILD in individuals from the target population to revise and refine the items according to instructions and guidelines of the final version of the questionnaire in the target language as well as to establish internal consistency reliability, test-retest reliability, homogeneity, construct-related validity, criterion-related validity, factor structure, and model fit of the instrument. Data will be collected from patients on both scales to assess for validity, reliability and psychometric properties. Reliability In the present study, the reliability of the CPCHILD will be determined by assessing test-retest reliability across repeated measures and internal consistency. Test-retest reliability: For test-retest reliability, the scale will be completed once a day by the same participant who keeping the same signs and symptoms. A time interval of 1 week will be allowed between the assessments. Intra class correlation coefficient (ICC) will be used to evaluate test- retest reliability. Internal consistency: Internal consistency is a measure of the extent to which items in a both scales are correlated (homogeneous), thus measuring the same concept. Cronbach's alpha will be calculated to determine the internal consistency. Content validity: Content validity is the degree to which the content of an instrument has an adequate reflection of the construct being measured. Content validity will be assessed by determining the completeness of item responses. Construct validity: Construct validity refers to the extent to which scores on a particular instrument relate to other measures in a way that is consistent with theoretically derived hypotheses concerning the concepts that are being measured. Construct validity will be investigated using concurrent validity. Construct validity will be assessed by measuring the correlation between CPCHILD scale and child health questionnaire. Spearman and Pearson correlation coefficients would be calculated for determining validity. Phase 3: A survey would be done to assess the level of disability and health status of cerebral palsy through CPCHILD questionnaire.


Recruitment information / eligibility

Status Completed
Enrollment 115
Est. completion date July 15, 2023
Est. primary completion date July 10, 2023
Accepts healthy volunteers No
Gender All
Age group 3 Years to 15 Years
Eligibility Inclusion Criteria: - Subjects diagnosed with cerebral palsy - Age 3 to 15 years - Gross motor function score II, III, IV Exclusion Criteria: - Cognitive, visual or hearing impairment - Any comorbidity or metabolic disorders

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Pakistan Rehman Medical Institute Peshawar KPK

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Caregiver priorities and child health index of life with disability (CPCHILD) Priorities of caregivers along with level of health status of the Cerebral Palsy child. The score ranges from 0 to 100, 0 is the best and 100 is worst. Baseline (one time assessment)
Primary Health Related Quality of Life (HRQoL) The tool is used to determine the quality of life and health status of subjects. The score ranges from 0 to 100, lower scores indicate better outcome and higher scores indicate worse outcome. Baseline (one time assessment)
Primary International physical activity questionnaire (IPAQ) International physical activity questionnaire (IPAQ) is used to determine the level of physical activity in certain population. The subjects may have the levels as; inactive, minimal active, moderate and highly active depending on the scores. Baseline (one time assessment)
Primary Health related quality of life (HRQoL) Health related quality of life (HRQoL) will be used to determine the quality of life in subjects with cerebral palsy Baseline (one time assessment)
Primary Pittsburgh Sleep questionnaire Pittsburgh Sleep questionnaire will be use to detrmine the quality of sleep in cerebral palsy subjects. Baseline (one time assessment)
Primary Trunk impairment scale Trunk impairment scale is used for trunk control. The lower the trunk control, the higher chances of disability in cerebral palsy subjects. Baseline (one time assessment)
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT04119063 - Evaluating Wearable Robotic Assistance on Gait Early Phase 1
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Recruiting NCT06450158 - Robot-assisted Training in Children With CP N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2